PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Furthermore, miR-181a expression levels were increased and SIRT1-PGC-1α pathway activity was decreased in the liver of dairy cows and patients with NAFLD, as well as in HFD mice and ob/ob mice and hepatocytes treated with NEFA, compared with the corresponding controls.